Cargando…

Infantile-onset Pompe disease complicated by sickle cell anemia: Case report and management considerations

Infantile-onset Pompe disease (IOPD) is a rare, severe disorder of lysosomal storage of glycogen that leads to progressive cardiac and skeletal myopathy. IOPD is a fatal disease in childhood unless treated with enzyme replacement therapy (ERT) from an early age. Sickle cell anemia (SCA) is a relativ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Starosta, Rodrigo Tzovenos, Hou, Ying-Chen Claire, Leestma, Katelyn, Singh, Prapti, Viehl, Luke, Manwaring, Linda, Granadillo, Jorge Luis, Schroeder, Molly C., Colombo, Jamie N., Whitehead, Halana, Dickson, Patricia Irene, Hulbert, Monica L., Nguyen, Hoanh Thi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555291/ https://www.ncbi.nlm.nih.gov/pubmed/36245745 http://dx.doi.org/10.3389/fped.2022.944178

Ejemplares similares

The Outcome of Infantile Onset Pompe Disease in South of Iran
por: Moravej, Hossein, et al.
Publicado: (2016)

The infantile-onset form of Pompe disease: an autopsy diagnosis
por: dos Santos, Otávio César Cruz, et al.
Publicado: (2015)

Atypical Infantile-onset Pompe Disease with Hypertrophic Cardiomyopathy
por: Quan, Jun-Jun, et al.
Publicado: (2017)

Nystagmus in infantile Pompe disease: a new feature?
por: Turco, Emanuela Claudia, et al.
Publicado: (2020)

Incidence of infantile Pompe disease in the Maroon population of French Guiana
por: Elenga, Narcisse, et al.
Publicado: (2018)

S2.2 Enzyme replacement therapy in the infantile-onset Pompe disease
por: Parenti, Giancarlo, et al.
Publicado: (2011)

Cognitive outcome of classic infantile Pompe patients receiving enzyme therapy
por: Ebbink, BJ, et al.
Publicado: (2013)

Clinical laboratory experience of blood CRIM testing in infantile Pompe disease
por: Bali, Deeksha S., et al.
Publicado: (2015)

Effects of immunomodulation in classic infantile Pompe patients with high antibody titers
por: Poelman, E., et al.
Publicado: (2019)

Infantile onset Pompe disease presenting with non-immune hydrops fetalis
por: Lee, Kristen, et al.
Publicado: (2019)

An 18-Month-Old Child with Infantile Pompe Disease: Oral Signs
por: Ceyhan, Derya, et al.
Publicado: (2017)

Adenotonsillectomy should be avoided whenever possible in infantile-onset Pompe disease
por: Jones, Harrison N., et al.
Publicado: (2020)

Recommendations for Infantile-Onset and Late-Onset Pompe Disease: An Iranian Consensus
por: Fatehi, Farzad, et al.
Publicado: (2021)

Blepharoptosis in infantile onset Pompe disease: Histological findings and surgical outcomes
por: Chen, Yi-Hua, et al.
Publicado: (2023)

The phenotype, genotype, and outcome of infantile-onset Pompe disease in 18 Saudi patients
por: Al-Hassnan, Zuhair N., et al.
Publicado: (2018)

Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease()
por: Chien, Yin-Hsiu, et al.
Publicado: (2017)

The Timely Needs for Infantile Onset Pompe Disease Newborn Screening—Practice in Taiwan
por: Chiang, Shu-Chuan, et al.
Publicado: (2020)

Infantile Pompe disease with intrauterine onset: a case report and literature review
por: Xi, Hongmin, et al.
Publicado: (2022)

Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease
por: Fiege, Lina, et al.
Publicado: (2023)

Anemia of Prematurity and Cerebral Near-Infrared Spectroscopy: Should transfusion thresholds in preterm infants be revised?
por: Whitehead, Halana V., et al.
Publicado: (2018)

Oral and Dental Considerations in Management of Sickle Cell Anemia
por: Acharya, Sonu
Publicado: (2015)

Antibody formation to enzyme therapy in classic infantile Pompe disease: implications of patient age
por: van Gelder, C, et al.
Publicado: (2013)

Muscle ultrasound: A useful tool in newborn screening for infantile onset pompe disease
por: Hwang, Hsuen-En, et al.
Publicado: (2017)

Infantile-onset Pompe disease with neonatal debut: A case report and literature review
por: Martínez, Miriam, et al.
Publicado: (2017)

Orofacial features and pediatric dentistry in the long-term management of Infantile Pompe Disease children
por: Galeotti, Angela, et al.
Publicado: (2020)

Clinical course, mutations and its functional characteristics of infantile-onset Pompe disease in Thailand
por: Ngiwsara, Lukana, et al.
Publicado: (2019)

Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy
por: Hsueh, Chien-Yu, et al.
Publicado: (2021)

To detect potential pathways and target genes in infantile Pompe patients using computational analysis
por: Karadağ Gürel, Aynur, et al.
Publicado: (2022)

Neurofilament Light and Its Association With CNS Involvement in Patients With Classic Infantile Pompe Disease
por: Mackenbach, Maarten J., et al.
Publicado: (2023)

Infantile‐onset Pompe disease with neutropenia: Treatment decisions in the face of a unique phenotype
por: Riedy, Mary, et al.
Publicado: (2022)

Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease
por: Kanters, Tim A, et al.
Publicado: (2014)

Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
por: Prater, Sean N, et al.
Publicado: (2013)

Long term outcome and clinical experience on immune tolerance induction therapies in infantile Pompe disease
por: Austin, Stephanie, et al.
Publicado: (2013)

CRIM-negative infantile Pompe disease: Characterization of immune responses in patients treated with ERT monotherapy
por: Berrier, Kathryn L., et al.
Publicado: (2015)

A Race Against Time—Changing the Natural History of CRIM Negative Infantile Pompe Disease
por: Gupta, Punita, et al.
Publicado: (2020)

Importance of Timely Treatment Initiation in Infantile-Onset Pompe Disease, a Single-Centre Experience
por: de las Heras, Javier, et al.
Publicado: (2021)

Immune responses to alglucosidase in infantile Pompe disease: recommendations from an Italian pediatric expert panel
por: Gragnaniello, Vincenza, et al.
Publicado: (2022)

Non-specificity of symptoms in infantile-onset Pompe disease may delay the diagnosis and institution of treatment
por: Senarathne, Udara Dilrukshi, et al.
Publicado: (2022)

Expert Group Consensus on early diagnosis and management of infantile-onset pompe disease in the Gulf Region
por: Al-Hassnan, Zuhair, et al.
Publicado: (2022)

Hypertrophy cardiomyopathy: A case of infantile-onset Pompe disease in cardiac magnetic resonance findings
por: Zhong, Yi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m3no5eug0l38k71sbcqtea5e86